You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker
- 2. Assessment of prostate cancer aggressiveness through the combined analysis of prostate MRI and 2.5D deep learning models
- 3. Prognostic value of lymph node ratio in patients with non-small cell lung cancer: a systematic review and meta-analysis
- 4. Aspirin a day keeps bowel cancer at bay
- 5. Scientists uncover immune cells that help prostate cancer resist treatment — and reveal a way to stop them
- 6. Top biotech deals in June 2025
- 7. Expression of Insulin-like growth factor 2 mRNA-binding protein 3 and its diagnostic value in breast cancer
- 8. Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds
- 9. The fatal mutation that lets cancer outsmart the human immune system
- 10. Health Check: Promedicus shares smash record $300 barrier on back of mega deals
Last updated at 21:02 GMT
Hot News Makers
Health/Pharma Companies
-
115870.18
-
64628.22
-
30627.70
-
10913.59
-
6782.65
-
6572.79
-
5752.37
-
5521.16
-
5021.41
-
4714.70
Drugs, Treatments, Trials
-
131994.93
-
15678.43
-
9881.57
-
8214.13
-
7153.54
-
6393.46
-
6099.83
-
3942.14
-
3528.79
-
2534.23
Last updated at 20:10 GMT
